QA: CORCEPT THERAPEUTICS INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001088856_2023_CORCEPT_THERAPEUTICS_INC.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001088856, CORCEPT THERAPEUTICS INC

  xvar xval
0 AssetsCurrent 499,253,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 633,000
3 remainder_Assets 83,544,000
4 LiabilitiesCurrent 72,491,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 9,097,000
7 CostOfGoodsAndServicesSold 5,385,000
8 SellingGeneralAndAdministrativeExpense 152,848,000
9 ResearchAndDevelopmentExpense 130,991,000
10 remainder_Expenses 14,773,000
11 remainder_Revenues 401,858,000
12 remainder_NetIncome 3,557,000
13 remainder_ComprehensiveNetIncome -642,000
  yvar yval
0 Assets 583,430,000
1 Liabilities 81,588,000
2 Expenses 303,997,000
3 Revenues 401,858,000
4 StockholdersEquity 501,842,000
5 NetIncome 101,418,000
6 ComprehensiveNetIncome 101,097,000
7 BaseVar 687,536,000
8 EconomicCapitalRatio 2.90

Edgar->Model Mapping

Feature Distribution

Change over Time